These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2832647)

  • 21. Hepatitis A in Peru. The role of children.
    Kilpatrick ME; Escamilla J
    Am J Epidemiol; 1986 Jul; 124(1):111-3. PubMed ID: 3013000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control.
    Whiteman D; McCall B; Falconer A
    J Viral Hepat; 1998 Jul; 5(4):277-83. PubMed ID: 9751015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM].
    Barin F; Lesage G; Dubois F; Yvonnet B; Coursaget P; Goudeau A
    Pathol Biol (Paris); 1983 Dec; 31(10):825-8. PubMed ID: 6322094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A seroprevalence rate in Syria.
    Antaki N; Kebbewar MK
    Trop Doct; 2000 Apr; 30(2):99-101. PubMed ID: 10842558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ELISA in the detection of hepatitis A: detection of anti-HAV IgM with F(ab')].
    Xu DZ
    Zhonghua Yi Xue Za Zhi; 1985 Jan; 65(1):34-6. PubMed ID: 2983848
    [No Abstract]   [Full Text] [Related]  

  • 26. [The relationship between changing of anti-HAV in population and prevalence of hepatitis A].
    Li L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):139-40. PubMed ID: 2555117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection.
    Sata M; Nakano H; Tanaka E; Kumashiro R; Suzuki H; Tanikawa K
    J Gastroenterol; 1996 Dec; 31(6):812-7. PubMed ID: 9027644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis].
    Angarano G; Coppola S; Frappampina V; Monno L; Santantonio T
    Boll Ist Sieroter Milan; 1982; 61(5):383-9. PubMed ID: 6100166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children.
    Tsega E; Nordenfelt E; Mengesha B; Hansson BG; Tsega M; Lindberg J
    Scand J Infect Dis; 1990; 22(2):145-8. PubMed ID: 2356438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical study of immunoglobulin class specific antibody response following hepatitis A.
    Sato A
    Gastroenterol Jpn; 1988 Apr; 23(2):129-38. PubMed ID: 2838373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan.
    Tanaka E; Matsumoto A; Takeda N; Li TC; Umemura T; Yoshizawa K; Miyakawa Y; Miyamura T; Kiyosawa K
    J Viral Hepat; 2005 Jul; 12(4):439-42. PubMed ID: 15985017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The latest seroepidemiological pattern of hepatitis A in Japan.
    Kiyohara T; Satoh T; Yamamoto H; Totsuka A; Moritsugu Y
    Jpn J Med Sci Biol; 1997 Jun; 50(3):123-31. PubMed ID: 9556753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis.
    Joon A; Rao P; Shenoy SM; Baliga S
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():102-5. PubMed ID: 25657123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
    Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
    World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy.
    Stroffolini T; Chiaramonte M; Franco E; Rapicetta M; De Mattia D; Mura I; Trivello R; Giammanco A; Rigo G; Scarpa B
    Infection; 1991; 19(2):97-100. PubMed ID: 1646772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.
    Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH
    Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.
    Das K; Jain A; Gupta S; Kapoor S; Gupta RK; Chakravorty A; Kar P
    Eur J Epidemiol; 2000 Jun; 16(6):507-10. PubMed ID: 11049092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decline in anti-HAV prevalence in the Milan area between 1958 and 1992.
    Zanetti AR; Romanò L; Tanzi E; Andreassi A; Pozzi A; Panuccio A; Stroffolini T
    Eur J Epidemiol; 1994 Oct; 10(5):633-5. PubMed ID: 7859866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.